FDA — authorised 18 January 2002
- Marketing authorisation holder: GALDERMA LABS LP
- Status: approved
🇺🇸 Tri-Luma in United States
FDA authorised Tri-Luma on 18 January 2002
Marketing authorisations
FDA — authorised 18 January 2002
- Application: NDA021112
- Marketing authorisation holder: GALDERMA LABS LP
- Local brand name: TRI-LUMA
- Indication: CREAM — TOPICAL
- Status: approved
Tri-Luma in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Tri-Luma approved in United States?
Yes. FDA authorised it on 18 January 2002; FDA authorised it on 18 January 2002.
Who is the marketing authorisation holder for Tri-Luma in United States?
GALDERMA LABS LP holds the US marketing authorisation.